SCHEMBL14810676

SCHEMBL14810676

C=Cc1cnc(OC)c(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 1/20 0.46
▸ TUBB1 Q9H4B7 5/20 0.42
▸ TUBB4A P04350 4/20 0.42
▸ TUBB P07437 4/20 0.42
▸ TUBA3C P0DPH7 4/20 0.42
▸ TUBA1B P68363 4/20 0.42
▸ TUBA4A P68366 4/20 0.42
▸ TUBB4B P68371 4/20 0.42
▸ TUBB3 Q13509 4/20 0.42
▸ TUBB2A Q13885 4/20 0.42
▸ TUBB8 Q3ZCM7 4/20 0.42
▸ TUBA3E Q6PEY2 4/20 0.42
▸ TUBA1A Q71U36 4/20 0.42
▸ TUBA1C Q9BQE3 4/20 0.42
▸ TUBB6 Q9BUF5 4/20 0.42
▸ TUBB2B Q9BVA1 4/20 0.42
▸ ALDH1A1 P00352 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ ALOX5 P09917 2/20 0.37
▸ STAT3 P40763 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29768997 1.00 TRPA1 (0.46) TRPA1TUBB1TUBB4ATUBBTUBA3C
SCHEMBL2698927 0.81 FDPS (0.51) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL29950972 0.81 FDPS (0.51) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL29769000 0.81 TRPA1 (0.34) TRPA1TUBB1TUBB4ATUBBTUBA3C
SCHEMBL24758373 0.81 TUBB1 (0.42) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL29768993 0.79 LMNA (0.38) TRPA1TUBB1TUBB4ATUBBTUBA3C
SCHEMBL27392980 0.79 LMNA (0.38) TRPA1TUBB1TUBB4ATUBBTUBA3C
SCHEMBL29208696 0.75 KDR (0.39) NFE2L2PIK3CA
SCHEMBL14486261 0.75 PDGFRB (0.61) TRPA1TUBB1TUBB4ATUBBTUBA3C
SCHEMBL14486254 0.75 PDGFRB (0.61) TRPA1TUBB1TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250108123-A1 COMPOUND-LINKER CONSTRUCTS COMPRISING NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2025-04-03 — — US disclosed
US-20240116909-A1 NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-04-11 — — US disclosed
WO-2024032782-A1 VACCINE ADJUVANTS AND USES THEREOF JACOBIO PHARMACEUTICALS CO.LTD. (CN) 2024-02-15 — — WO disclosed
US-20240043386-A1 Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use ABBVIE GLOBAL ENTPR LTD (BM) 2024-02-08 — — US disclosed
EP-4313962-A1 NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF Jacobio Pharmaceuticals Co., Ltd. (CN) 2024-02-07 — — EP disclosed
CN-117203194-A Novel compounds useful as STING agonists and uses thereof 北京加科思新药研发有限公司 2023-12-08 — — CN disclosed
US-11702430-B2 Aza-benzothiophene compounds as STING agonists MERCK SHARP & DOHME LLC (US) 2023-07-18 — — US disclosed
US-11702430-B2 Aza-benzothiophene compounds as STING agonists MERCK SHARP & DOHME LLC (US) 2023-07-18 — — US disclosed
US-11702430-B2 Aza-benzothiophene compounds as STING agonists MERCK SHARP & DOHME LLC (US) 2023-07-18 — — US disclosed
WO-2023109942-A1 COMPOUND-LINKER CONSTRUCTS COMPRISING NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2023-06-22 — — WO disclosed
US-20150329545-A1 FSH RECEPTOR ANTAGONISTS MERCK SHARP & DOHME B.V. (NL) 2015-11-19 — — US disclosed
US-9127007-B2 FSH receptor antagonists MERCK SHARP & DOHME B.V. (NL) 2015-09-08 — — US disclosed
US-9127007-B2 FSH receptor antagonists MERCK SHARP & DOHME B.V. (NL) 2015-09-08 — — US disclosed
US-9127007-B2 FSH receptor antagonists MERCK SHARP & DOHME B.V. (NL) 2015-09-08 — — US disclosed
US-20140350043-A1 FSH RECEPTOR ANTAGONISTS MERCK SHARP & DOHME B.V. (NL) 2014-11-27 — — US disclosed
US-20140350043-A1 FSH RECEPTOR ANTAGONISTS MERCK SHARP & DOHME B.V. (NL) 2014-11-27 — — US disclosed
US-20140350043-A1 FSH RECEPTOR ANTAGONISTS MERCK SHARP & DOHME B.V. (NL) 2014-11-27 — — US disclosed
EP-2763986-A1 FSH RECEPTOR ANTAGONISTS Merck Sharp & Dohme B.V. (NL) 2014-08-13 — — EP disclosed
WO-2013041458-A1 FSH RECEPTOR ANTAGONISTS MSD OSS B.V. (NL) 2013-03-28 — — WO disclosed
WO-2013041458-A1 FSH RECEPTOR ANTAGONISTS MSD OSS B.V. (NL) 2013-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350043-A1 FSH RECEPTOR ANTAGONISTS FSHR, GNRHR, LHCGR TRPA1 1905/4885TUBB1 3121/4885TUBB4A 3867/4885
US-20240043386-A1 Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use CFTR, SLC47A1, SLC47A2 TRPA1 88/4885TUBB1 3536/4885TUBB4A 3968/4885
US-20240116909-A1 NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF STING1, CGAS, IRF3 TRPA1 548/4885TUBB1 3840/4885TUBB4A 3289/4885
US-11702430-B2 Aza-benzothiophene compounds as STING agonists STING1, IRF3, CGAS TRPA1 1071/4885TUBB1 3147/4885TUBB4A 2725/4885
US-20250108123-A1 COMPOUND-LINKER CONSTRUCTS COMPRISING NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF STING1, IRF3, CGAS TRPA1 2763/4885TUBB1 3414/4885TUBB4A 3659/4885
US-20150329545-A1 FSH RECEPTOR ANTAGONISTS FSHR, GNRHR, LHCGR TRPA1 2211/4885TUBB1 3386/4885TUBB4A 4181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback